Roche Buys THP

Roche has acquired Therapeutic Human Polyclonals Inc., a Mountain View, Calif.-based developer of antibody therapeutics. No financial terms were disclosed. VentureWire reports that THP had raised $12 million in VC funding from Research Corp. Technologies and SangStat Medical Corp. (later acquired by Genzyme). www.roche.com